Intra-Cellular Therapies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITCI and other ETFs, options, and stocks.

About ITCI

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. 

CEO
Sharon L. Mates
CEOSharon L. Mates
Employees
610
Employees610
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2002
Founded2002
Employees
610
Employees610

ITCI Key Statistics

Market cap
7.27B
Market cap7.27B
Price-Earnings ratio
-47.18
Price-Earnings ratio-47.18
Dividend yield
Dividend yield
Average volume
899.52K
Average volume899.52K
High today
$71.35
High today$71.35
Low today
$68.48
Low today$68.48
Open price
$71.07
Open price$71.07
Volume
909.10K
Volume909.10K
52 Week high
$84.89
52 Week high$84.89
52 Week low
$45.50
52 Week low$45.50

Analyst ratings

88%

of 16 ratings
Buy
87.5%
Hold
12.5%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.